Third generation schizophrenia drugs look promising
Fewer side effects. Manages the glutamate-NMDA receptor mediation path.
where ignorance meets a little less ignorance
Fewer side effects. Manages the glutamate-NMDA receptor mediation path.
Posted by
echo
at
Monday, September 10, 2007
No comments:
Post a Comment